|
US2021093669A1
|
|
Primary T-Cell Expansion
|
|
WO2021041886A1
|
|
Modified n-810 and methods therefor
|
|
WO2021030662A1
|
|
Tgf-beta trap
|
|
WO2020092387A1
|
|
Self replicating rna system
|
|
WO2020081859A1
|
|
Mesenchymal stem cell derived exosomes and methods
|
|
WO2020072540A1
|
|
A dual inhibitor of wnt/beta-catenin & sonic hedgehog signal transduction pathways
|
|
US2020087680A1
|
|
Conditional Living Sensors
|
|
WO2020051363A1
|
|
Targeted il-12 treatments and methods to stimulate hank and nk92mi cells
|
|
WO2020046835A1
|
|
Rp182 compositions and methods
|
|
WO2020037120A1
|
|
Il7-il15 txm compositions and methods
|
|
EP3737411A1
|
|
Cellular adjuvants for viral infection
|
|
WO2020033366A1
|
|
Recombinant cd1-restricted t cells and methods
|
|
WO2020023713A1
|
|
Tri-cytokine txm compositions and methods
|
|
WO2019241592A1
|
|
Tnf-type receptor-ligand fusion proteins and methods
|
|
US2019367568A1
|
|
Calreticulin and fusion proteins
|
|
WO2020159524A1
|
|
Mrna display antibody library and methods
|
|
US2019264195A1
|
|
mRNA DISPLAY ANTIBODY LIBRARY AND METHODS
|
|
CN111868077A
|
|
Enhanced immunogenicity of GPI-anchored antigens
|
|
TW201938196A
|
|
Fusion protein extensions
|
|
US2020354679A1
|
|
Reprogrammed T Cell-Like NK Cells
|
